Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -10 of 30
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
1.
Phase II-III Chemotherapy with Ftorafur vs 5-FU/MeCCNU/TZT vs 5-FU/MeCCNU/ICRF-159 vs 5-FU/MeCCNU/VCR for Advanced Colorectal Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III, Phase II
Treatment
Closed
no age specified
MAYO-764802
Last Modified:
2/9/2008
2.
Phase III Randomized Study of Oral Uracil/Tegafur (UFT) with Leucovorin vs Fluorouracil with Leucovorin Following Resection for Stage II/III Adenocarcinoma of the Colon
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
no age specified
NCI
NSABP-C-06
NCT00378716
3.
Phase III Oral Tegafur vs Intravenous 5-Fluorouracil for Advanced Carcinoma of the Colon and Rectum
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
no age specified
UCCRC-2993
NCI-V83-0142
Last Modified:
7/1/1995
4.
Phase I/II Study of Oral UFT (Uracil/Tegafur) with CF for Advanced Solid Tumors (Summary Last Modified 07/95)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Closed
18 and over
MSKCC-92037A1
NCI-V92-0097
5.
Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Colorectal Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Closed
20 to 85
Other
CRC-A02-I, II
NCT00677612
Last Modified:
3/1/2000
 
First Published:
3/1/1998
6.
Phase II Study of Oral Uracil and Tegafur Plus Leucovorin Calcium in Advanced Local-Regional or Metastatic Squamous Cell Carcinoma of the Head and Neck (Summary Last Modified 03/2000)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
NCI
DFCI-96082
BMS-CA146-020, MGH-M6-37, NCI-G98-1384
7.
Phase II Chemotherapy with Ftorafur for Metastatic Adenocarcinoma of the Colon and Rectum
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
no age specified
NCI
SWOG-7619
8.
Phase II Chemotherapy with MeCCNU/TGDR vs MITO/TGDR vs MITO/5-FU for Refractory Disseminated Colorectal Carcinoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
no age specified
NCI
SWOG-7634
9.
Phase II Comparison of Ftorafur/MITO-C vs Ftorafur/MeCCNU for Adenocarcinoma of the Colon and Rectum
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
no age specified
WSU-C-19676
10.
Phase II Chemotherapy with Ftorafur for Adenocarcinoma of the Colon and Rectum After Prior Treatment with 5-FU or FUDR
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
no age specified
WSU-C-20276
Select All on One Page
1
2
3
Next >
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute